|
| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Protalix BioTherapeutics Inc is a part of the healthcare domain. It is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa, for the treatment of Gaucher disease. Its products also treat diseases like Fabry disease and cystic fibrosis. Its pipeline products include Alidornase Alfa, Pegunigalsidase Alfa, and Oprx-106.
 Be the first to like this.   Tygobar Yes, medical startups usually should very very good in everything like that really and totally , yet you do have very low price of the stock here, how can you really even describe this ? Could you damn let me know this please. I am all ears for example. 01/09/2019 1:12 PM  Lalis I do hope that medical things will be really our future and not just cause it cause something for example good for now, but in the real perspective for many many generations ahead totally. But for now of course I plan to invest a lot in such things. 07/09/2019 1:56 PM |
|
